Amrapali Industries Q2 FY26: Explosive Revenue Growth Masks Razor-Thin Margins

Nov 18 2025 05:18 PM IST
share
Share Via
Amrapali Industries Ltd., an Ahmedabad-based stock and commodity brokerage firm operating in entertainment, bullion trading, and share trading, reported a net profit of ₹0.37 crores for Q2 FY26, marking a dramatic 270.00% year-on-year surge from ₹0.10 crores in Q2 FY25. However, the sequential growth proved anaemic at just 2.78% from Q1 FY26's ₹0.36 crores. The micro-cap company, with a market capitalisation of ₹82.00 crores, saw its stock trade at ₹15.65 on November 18, down 1.20% from the previous session, reflecting investor scepticism despite the headline growth numbers.





Net Profit (Q2 FY26)

₹0.37 Cr

▲ 270.00% YoY



Revenue (Q2 FY26)

₹10,698 Cr

▲ 33.21% YoY



PAT Margin

0.00%

Razor-thin



Average ROE

3.83%

Below par




The quarter's performance reveals a company grappling with the fundamental challenge of translating massive revenue growth into meaningful profitability. While net sales surged 127.55% quarter-on-quarter to ₹10,698.34 crores from ₹4,701.49 crores, the operating profit margin excluding other income remained stuck at a meagre 0.02%, barely changed from the previous quarter's 0.03%. This trading-intensive business model generates enormous turnover but captures minimal value, raising questions about sustainable competitive advantages and pricing power.



Financial Performance: Growth Without Profitability



Amrapali Industries' Q2 FY26 financial performance presents a paradox: explosive top-line expansion coupled with persistently anaemic margins. Net sales of ₹10,698.34 crores represented a 127.55% sequential jump and a 33.21% year-on-year increase, driven primarily by heightened trading activity in the company's bullion and share trading segments. However, operating profit before depreciation, interest, tax, and other income (PBDIT excl OI) stood at just ₹2.09 crores, translating to an operating margin of merely 0.02%.





Revenue (Q2 FY26)

₹10,698 Cr

▲ 127.55% QoQ | ▲ 33.21% YoY



Net Profit (Q2 FY26)

₹0.37 Cr

▲ 2.78% QoQ | ▲ 270.00% YoY



Operating Margin

0.02%

Unchanged QoQ



PAT Margin

0.00%

Razor-thin




The profit after tax margin remained virtually non-existent at 0.00%, underscoring the capital-intensive, low-margin nature of the trading and distribution business. Employee costs remained controlled at ₹0.41 crores, but interest expenses surged to ₹1.88 crores from ₹1.45 crores sequentially, reflecting increased working capital requirements to support the expanded trading volumes. The tax rate of 30.19% in Q2 FY26 appeared more normalised compared to the volatile rates seen in previous quarters, ranging from negative 3.70% to 94.59%.



On a half-yearly basis (H1 FY26), the company reported combined net sales of ₹15,399.83 crores, a significant improvement over comparable periods. However, the combined net profit for H1 FY26 stood at just ₹0.73 crores, highlighting the persistent challenge of converting massive turnover into sustainable bottom-line growth. The quality of earnings remains questionable, with other income contributing ₹0.72 crores in Q2 FY26, representing a substantial portion of the pre-tax profit of ₹0.53 crores.

















































































Metric Sep'25 Jun'25 Mar'25 Dec'24 Sep'24
Net Sales (₹ Cr) 10,698.34 4,701.49 3,253.09 11,473.05 8,031.28
QoQ Growth +127.55% +44.52% -71.65% +42.85% +175.01%
YoY Growth +33.21% +60.99% -36.75%
Net Profit (₹ Cr) 0.37 0.36 1.00 0.28 0.10
QoQ Growth +2.78% -64.00% +257.14% +180.00% -60.00%
YoY Growth +270.00% +44.00% +3233.33%
Operating Margin (%) 0.02% 0.03% -0.05% 0.03% 0.00%
PAT Margin (%) 0.00% 0.01% 0.03% 0.00% 0.00%



Operational Challenges: Capital Efficiency Concerns



The operational metrics paint a concerning picture of capital efficiency and return generation. The average return on equity (ROE) of 3.83% ranks significantly below acceptable thresholds for equity investments, indicating that the company generates minimal returns on shareholder capital. For context, higher ROE values signify better capital efficiency and profitability—Amrapali's 3.83% suggests the company earns less than ₹4 for every ₹100 of equity invested, a level that barely exceeds risk-free returns available from fixed-income instruments.




Critical Capital Efficiency Issues


Average ROE: 3.83% (significantly below acceptable levels)


Average ROCE: 1.54% (extremely weak)


Debt to EBITDA: 25.91x (dangerously high leverage)


Net Debt to Equity: 4.40x (excessive financial risk)


The company's ability to generate returns on invested capital remains severely constrained, with operational profitability insufficient to justify the elevated debt burden.




The return on capital employed (ROCE) of 1.54% proves even more troubling, indicating that the company barely generates any returns on the total capital deployed in the business. The EBIT to interest coverage ratio of just 0.37x reveals that operating profits fail to cover interest expenses, forcing the company to rely on other income to meet debt obligations. This precarious financial structure becomes particularly concerning when examining the debt metrics: a debt to EBITDA ratio of 25.91x and net debt to equity of 4.40x indicate excessive leverage for a business generating such minimal operating profits.



The balance sheet as of March 2025 showed shareholder funds of ₹33.02 crores against current liabilities of ₹84.08 crores, with current assets of ₹94.65 crores providing some liquidity cushion. However, the absence of long-term debt doesn't necessarily signal strength—it more likely reflects the company's inability to access long-term financing given its weak profitability profile. The cash flow statement for FY25 revealed negative operating cash flow of ₹6.00 crores, with the company generating cash through investing activities (₹10.00 crores) rather than core operations, another red flag for sustainability.



Valuation Analysis: Expensive Despite Weak Fundamentals



Amrapali Industries trades at a price-to-earnings ratio of 40.49x, representing a significant premium to the industry average P/E of 32x despite demonstrably weaker fundamentals. This valuation disconnect appears unjustified when considering the company's marginal profitability, weak return ratios, and high leverage. The price-to-book value of 2.41x means investors pay ₹2.41 for every rupee of book value, a premium that typically requires superior ROE—which Amrapali clearly lacks at 3.83%.





P/E Ratio (TTM)

40.49x

vs Industry: 32x



Price to Book Value

2.41x

Premium valuation



EV/EBITDA

45.27x

Stretched multiple



Valuation Grade

EXPENSIVE

Overvalued




The enterprise value to EBITDA multiple of 45.27x appears particularly stretched for a low-margin trading business with inconsistent cash generation. The valuation grade has oscillated between "Expensive" and "Fair" multiple times over the past year, currently sitting at "Expensive" as of September 23, 2025. The stock trades at ₹15.65, approximately 22.68% below its 52-week high of ₹20.24 but still 11.39% above its 52-week low of ₹14.05, suggesting limited downside cushion given the fundamental weaknesses.



The absence of dividend yield eliminates any income component to total returns, making investors entirely dependent on capital appreciation—a challenging proposition given the company's inability to meaningfully grow profitability despite revenue expansion. The PEG ratio of 0.15x might appear attractive superficially, but this metric becomes less meaningful when the underlying earnings quality remains questionable and growth proves volatile rather than sustainable.

































































Company P/E (TTM) P/BV Avg ROE Debt/Equity Market Cap
Amrapali Inds. 40.49 2.41 3.83% 4.40 ₹82 Cr
Genpharmasec 158.06 1.32 1.05% 0.09
Ganesha Ecoverse NA (Loss Making) 1.45 9.43% 0.18
Constronics 17.37 1.97 20.02% -0.17
Gautam Exim 568.80 5.55 3.72% 0.02
Growington Vent 17.33 3.84 8.72% 0.29



Compared to peers in the Trading & Distributors sector, Amrapali Industries exhibits one of the highest debt-to-equity ratios at 4.40x while generating amongst the lowest ROE at 3.83%. Companies like Constronics demonstrate that superior returns (20.02% ROE) can justify premium valuations, but Amrapali's fundamental profile doesn't support its current P/E multiple. The peer comparison reinforces the conclusion that Amrapali trades at an unjustified premium relative to its operational performance and capital efficiency.



Shareholding Pattern: Stable but Uninspiring



The shareholding pattern reveals a promoter-dominated structure with minimal institutional participation, a characteristic that often correlates with limited liquidity and research coverage. Promoter holding has remained static at 73.43% across the last five quarters, indicating no change in management commitment but also no fresh capital infusion. The promoter group, led by Yashwant Amratlal Thakkar with 50.34%, maintains control without any pledging of shares—a positive indicator that at least eliminates one potential risk factor.

































































Category Sep'25 Jun'25 Mar'25 Dec'24 QoQ Change
Promoter 73.43% 73.43% 73.43% 73.43% 0.00%
FII 0.00% 0.00% 0.00% 0.00% 0.00%
Mutual Funds 0.00% 0.00% 0.00% 0.00% 0.00%
Insurance 0.00% 0.00% 0.00% 0.00% 0.00%
Other DII 0.00% 0.00% 0.00% 0.00% 0.00%
Non-Institutional 26.57% 26.57% 26.57% 26.57% 0.00%



The complete absence of foreign institutional investors (FII), mutual funds, insurance companies, and other domestic institutional investors (DII) speaks volumes about the stock's appeal to professional money managers. Zero institutional holding typically indicates either inadequate disclosure standards, insufficient liquidity, or fundamental concerns that keep sophisticated investors away. For retail investors, this absence of institutional validation should serve as a significant warning signal, as it suggests the stock lacks the quality metrics and governance standards that attract long-term institutional capital.



The non-institutional holding of 26.57% comprises primarily retail investors and non-institutional entities, a shareholder base that tends to be more volatile and less patient during periods of underperformance. The lack of any movement in shareholding percentages over five consecutive quarters suggests minimal trading interest and poor liquidity, which could make exit difficult for investors during times of stress.



Stock Performance: Consistent Underperformance



The stock's price performance reveals a consistent pattern of underperformance against both the benchmark Sensex and the broader Trading & Distributors sector. Over the past year, Amrapali Industries declined 5.95% whilst the Sensex gained 9.48%, resulting in a negative alpha of 15.43 percentage points. This underperformance extends across multiple timeframes, with the stock generating negative alpha over three months (-9.10%), six months (-7.42%), and year-to-date (-17.85%).





































































Period Stock Return Sensex Return Alpha
1 Week +2.42% +0.96% +1.46%
1 Month +1.76% +0.86% +0.90%
3 Months -4.92% +4.18% -9.10%
6 Months -4.57% +2.85% -7.42%
YTD -9.49% +8.36% -17.85%
1 Year -5.95% +9.48% -15.43%
2 Years +5.53% +28.69% -23.16%
3 Years +14.74% +37.31% -22.57%
5 Years +299.23% +91.65% +207.58%



The technical picture reinforces the bearish fundamental narrative. The stock entered a bearish trend on October 31, 2025, at ₹15.80, and currently trades below all key moving averages—5-day (₹15.56), 20-day (₹15.46), 50-day (₹15.73), 100-day (₹15.75), and 200-day (₹15.88). This alignment of moving averages in resistance mode typically indicates sustained selling pressure and lack of buying conviction. The MACD indicator shows bearish signals on both weekly and monthly timeframes, whilst the Bollinger Bands suggest bearish momentum with the stock trading near the lower band.



The risk-adjusted return profile appears particularly unattractive, with a negative Sharpe ratio over the one-year period and volatility of 44.72%—more than three times the Sensex volatility of 12.26%. The stock's beta of 1.50 classifies it as high beta, meaning it tends to amplify market movements, but crucially, this higher risk hasn't translated into higher returns. Instead, investors have experienced elevated volatility with negative returns, the worst possible combination. Against the Trading & Distributors sector, which itself declined 20.81% over the past year, Amrapali's 5.95% decline represents relative outperformance of 14.86 percentage points—though outperforming a weak sector provides cold comfort.




"A company generating 3.83% ROE whilst trading at 40x earnings and carrying 4.40x net debt-to-equity represents a fundamental disconnect that typically resolves through price correction rather than operational improvement."


Investment Thesis: Multiple Red Flags Outweigh Limited Positives



The investment thesis for Amrapali Industries faces significant headwinds across all critical parameters. The proprietary Mojo Score of 31 out of 100, resulting in a "SELL" rating, reflects the confluence of weak fundamentals, stretched valuation, bearish technicals, and poor quality metrics. The company's quality grade of "Below Average" stems from its weak long-term financial performance, with five-year EBIT growth of -21.03% despite sales growth of 15.82%, indicating deteriorating operational efficiency and margin compression over time.





Valuation

EXPENSIVE

Overvalued



Quality Grade

BELOW AVG

Weak fundamentals



Financial Trend

POSITIVE

Short-term only



Technical Trend

BEARISH

Downtrend




The short-term financial trend classification of "Positive" based on Q2 FY26 results provides the only bright spot, but this must be contextualised against the extremely low base and questionable sustainability. The 270.00% year-on-year profit growth sounds impressive until one realises it represents an increase from ₹0.10 crores to ₹0.37 crores—absolute numbers that remain immaterial for a company with ₹10,698 crores in quarterly revenue. The positive trend reflects relative improvement rather than absolute strength.



Key Strengths & Risk Factors





Key Strengths



  • Revenue Growth Momentum: Demonstrated ability to scale turnover significantly, with Q2 FY26 sales up 127.55% QoQ and 33.21% YoY

  • No Promoter Pledging: Zero pledging of promoter shares eliminates one potential governance risk

  • Stable Promoter Base: Consistent 73.43% promoter holding indicates management commitment

  • Improved Tax Normalisation: Tax rate of 30.19% in Q2 FY26 suggests more predictable tax structure going forward

  • Long-term Track Record: Five-year return of 299.23% demonstrates historical wealth creation capability




Key Concerns



  • Razor-Thin Margins: Operating margin of 0.02% and PAT margin of 0.00% indicate virtually no pricing power or competitive advantage

  • Extremely Weak ROE: Average ROE of 3.83% barely exceeds risk-free rates, signalling poor capital efficiency

  • Dangerous Leverage: Debt-to-EBITDA of 25.91x and net debt-to-equity of 4.40x create significant financial risk

  • Inadequate Interest Coverage: EBIT-to-interest ratio of 0.37x means operating profits fail to cover debt servicing costs

  • Zero Institutional Interest: Complete absence of FII, MF, and DII holdings signals quality concerns

  • Negative Operating Cash Flow: FY25 operating cash flow of -₹6.00 crores raises sustainability questions

  • Consistent Underperformance: Negative alpha across 1-year, 2-year, and 3-year periods versus benchmark





Outlook: What to Watch





Positive Catalysts



  • Sustained margin improvement to at least 1-2% operating margin levels

  • Reduction in debt-to-equity ratio below 2.0x through deleveraging

  • Achievement of ROE above 12-15% consistently

  • Entry of institutional investors signalling quality improvement

  • Positive operating cash flow generation for consecutive quarters




Red Flags to Monitor



  • Further margin compression below current 0.02% levels

  • Inability to service debt leading to defaults or restructuring

  • Continued negative operating cash flows requiring external financing

  • Promoter stake dilution or emergence of pledging

  • Technical breakdown below ₹14.05 (52-week low) support level






The Verdict: Avoid This Value Trap


SELL

Score: 31/100


For Fresh Investors: Avoid initiating any position. The combination of expensive valuation (40x P/E), weak fundamentals (3.83% ROE), dangerous leverage (4.40x net debt-to-equity), and bearish technical setup creates an unfavourable risk-reward profile. The 270% YoY profit growth sounds impressive but represents an increase from ₹0.10 crores to ₹0.37 crores—immaterial in absolute terms and unsustainable given the structural margin challenges.


For Existing Holders: Consider exiting on any technical bounce towards ₹16-17 levels. The stock trades at an unjustified premium despite demonstrable operational weaknesses. The absence of institutional investors, razor-thin margins, and excessive leverage create significant downside risk. The recent positive financial trend represents tactical improvement rather than strategic transformation.


Fair Value Estimate: ₹10-12 (36-43% downside from current levels) based on normalised 20x P/E on sustainable earnings of ₹0.50 crores annually, adjusted for quality and risk factors.





Note- ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)





⚠️ Investment Disclaimer


This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance does not guarantee future results, and all investments carry risk of loss.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Amrapali Inds. falling/rising?
Nov 29 2025 12:48 AM IST
share
Share Via
How has been the historical performance of Amrapali Inds.?
Nov 24 2025 11:09 PM IST
share
Share Via
Is Amrapali Inds. overvalued or undervalued?
Nov 18 2025 08:21 AM IST
share
Share Via
How has been the historical performance of Amrapali Inds.?
Nov 17 2025 11:07 PM IST
share
Share Via
How has been the historical performance of Amrapali Inds.?
Nov 14 2025 11:56 PM IST
share
Share Via
Why is Amrapali Inds. falling/rising?
Sep 25 2025 10:21 PM IST
share
Share Via